Related Experiment Video
Updated: Feb 1, 2026

Molecular Profiling of the Invasive Tumor Microenvironment in a 3-Dimensional Model of Colorectal Cancer Cells and Ex vivo Fibroblasts
Published on: April 29, 2014
TRIM14 promotes colorectal cancer cell migration and invasion through the SPHK1/STAT3 pathway
Zhonghai Jin1, Hongguang Li1, Xiaofei Hong1
1Department of Gastroenterology, Yiwu Hospital, Wenzhou Medical University, 699 Jiangdong Middle Road, Yiwu, 322000 China.
Background:
Colorectal cancer (CRC) is one of the most lethal malignancies. Tripartite Motif Containing 14 (TRIM14) is a member of TRIM family proteins, which are involved in the pathogenesis of various cancers. This study aimed to investigate TRIM14 expression in CRC tissues, and its effects on the migration and invasion of CRC cell lines.
Methods:
TRIM14 mRNA expression was detected by real-time PCR analysis. Cell migration and invasion were measured by Transwell assays. Protein expression was assessed by western blot analysis.
Results:
The expression of TRIM14 was significantly higher in CRC tissues than in matched non-cancerous tissues. TRIM14 knockdown by specific short hairpin RNA (shRNA) attenuated CRC cell migration and invasion, whereas TRIM14 overexpression caused reverse effect. Moreover, TRIM14 positively regulated the protein levels of sphingosine kinase 1 (SPHK1) and phosphorylated STAT3 (p-STAT3), as well as the mRNA and protein expression of matrix metalloproteinase 2, MMP9 and vascular endothelial growth factor, which are transcriptional targets of the STAT3 signaling pathway. Importantly, the blockage of the SPHK1/STAT3 signaling pathway by SKI-II or AG490 could reverse the TRIM14-promoted CRC cell migration and invasion.
Conclusions:
Our results reveal a critical role for TRIM14 in promoting migration and invasion of CRC cells, and suggest TRIM14 may serve as a potential molecular target to prevent CRC metastasis.
Insights
Tripartite Motif Containing 14 (TRIM14) promotes colorectal cancer (CRC) cell migration and invasion. Targeting TRIM14 may offer a new strategy to prevent CRC metastasis.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Colorectal cancer (CRC) is a leading cause of cancer mortality.
- Tripartite Motif Containing 14 (TRIM14), a TRIM family protein, is implicated in various cancers.
- Understanding TRIM14's role in CRC is crucial for developing new therapies.
Purpose of the Study:
- To investigate TRIM14 expression levels in colorectal cancer tissues.
- To determine the impact of TRIM14 on colorectal cancer cell migration and invasion.
- To elucidate the molecular mechanisms underlying TRIM14's function in CRC.
Main Methods:
- Quantitative real-time PCR for TRIM14 mRNA expression.
- Transwell assays to assess cell migration and invasion.
- Western blot analysis for protein expression and signaling pathway activation.
Main Results:
- TRIM14 expression is significantly upregulated in CRC tissues compared to non-cancerous tissues.
- TRIM14 knockdown inhibits CRC cell migration and invasion; overexpression enhances these processes.
- TRIM14 positively regulates Sphingosine Kinase 1 (SPHK1) and STAT3 signaling, including MMP2, MMP9, and VEGF expression.
- Inhibition of the SPHK1/STAT3 pathway reverses TRIM14-induced CRC cell migration and invasion.
Conclusions:
- TRIM14 plays a critical role in promoting colorectal cancer cell migration and invasion.
- TRIM14 emerges as a potential molecular target for preventing CRC metastasis.
- Targeting TRIM14 and its associated signaling pathways could offer novel therapeutic strategies for CRC.
Related Concept Videos
Cancer Cell Migration through Invadopodia
Cell Migration
Cell Migration
The Eukaryotic Promoter Region
The Eukaryotic Promoter Region
Chemotaxis and Direction of Cell Migration

